Identification and Management of Polyvascular Disease in Patients with Noncardioembolic Ischaemic Stroke

Recent registry results have shown that polyvascular disease (PolyVD), usually manifested as coronary heart disease or peripheral arterial disease (PAD), is a marker of increased morbidity and mortality in patients with noncardioembolic ischaemic stroke, but is often inadequately assessed. This Personal View Paper advocates routine examination for PolyVD in such patients. Peripheral arterial disease can be readily detected in routine practice by measurement of the ankle-brachial index. This paper makes recommendations for risk stratification, discharge documentation and, where possible, management of ischaemic stroke patients with PolyVD.

[1]  鮫島 浩,et al.  Population-based study からみた神経予後不良因子の検討 , 2009 .

[2]  D. Sander,et al.  Kidney function and progression of carotid intima-media thickness in a community study. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[3]  K. Furie,et al.  Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2008, Circulation.

[4]  D. Sander,et al.  High-Sensitivity C-Reactive Protein Is Independently Associated With Early Carotid Artery Progression in Women But Not in Men: The INVADE Study , 2007, Stroke.

[5]  T. Olsen,et al.  Higher Total Serum Cholesterol Levels Are Associated With Less Severe Strokes and Lower All-Cause Mortality: Ten-Year Follow-Up of Ischemic Strokes in the Copenhagen Stroke Study , 2007, Stroke.

[6]  A. Lincoff,et al.  Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials. , 2007, JAMA.

[7]  Shah Ebrahim,et al.  European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invit , 2007, European heart journal.

[8]  A. Dominiczak,et al.  2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. , 2007, Journal of hypertension.

[9]  Shah Ebrahim,et al.  Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts) , 2007 .

[10]  H. Diener,et al.  Systemic Risk Score Evaluation in Ischemic Stroke Patients (SCALA) , 2007, Journal of Neurology.

[11]  William Wijns,et al.  [Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes]. , 2007, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[12]  J. Hauw,et al.  Autopsy Prevalence of Coronary Atherosclerosis in Patients With Fatal Stroke , 2007, Stroke.

[13]  D. Betteridge,et al.  Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04) , 2007, Stroke.

[14]  C. Cimminiello,et al.  Low ankle–brachial index predicts an adverse 1‐year outcome after acute coronary and cerebrovascular events , 2006, Journal of thrombosis and haemostasis : JTH.

[15]  H. Boshuizen,et al.  Effects of past and recent blood pressure and cholesterol level on coronary heart disease and stroke mortality, accounting for measurement error. , 2006, American journal of epidemiology.

[16]  A. Folsom,et al.  Risk Factors for Ischemic Stroke Subtypes: The Atherosclerosis Risk in Communities Study , 2006, Stroke.

[17]  G. Navis,et al.  Incidental renal artery stenosis is an independent predictor of mortality in patients with peripheral vascular disease. , 2006, Journal of the American Society of Nephrology : JASN.

[18]  J. Allenberg,et al.  Association of low ankle brachial index with high mortality in primary care. , 2006, European heart journal.

[19]  C. Cimminiello,et al.  The Stroke in Italy and Related Impact on Outcome (SIRIO) study: design and baseline data , 2006, Neurological Sciences.

[20]  A. Algra,et al.  Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial , 2006, The Lancet.

[21]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. , 2006, Journal of the American College of Cardiology.

[22]  M. Pfeffer,et al.  AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. , 2006, Circulation.

[23]  R. Sacco,et al.  Recurrent stroke and cardiac risks after first ischemic stroke , 2006, Neurology.

[24]  Rodney A. White,et al.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography , 2006, Circulation.

[25]  B. Conrad,et al.  Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. , 2006, Stroke.

[26]  V. Chair,et al.  Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the , 2006, Circulation.

[27]  Deepak L. Bhatt,et al.  International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. , 2006, JAMA.

[28]  J. Camm,et al.  [Guidelines on the management of stable angina pectoris: executive summary]. , 2006, Giornale italiano di cardiologia.

[29]  J J Bax,et al.  Cardiac applications of multislice computed tomography. , 2006, The British journal of radiology.

[30]  D. Leys,et al.  Detection and Management of Associated Atherothrombotic Locations in Patients with a Recent Atherothrombotic Ischemic Stroke: Results of the DETECT Survey , 2006, Cerebrovascular Diseases.

[31]  A. Alpérovitch,et al.  [Prevalence of asymptomatic atherothrombotic lesions and risk of vascular events in patients with a stroke]. , 2005, Archives des maladies du coeur et des vaisseaux.

[32]  Sonia S. Anand,et al.  Sensitivity and Specificity of the Ankle–Brachial Index to Predict Future Cardiovascular Outcomes: A Systematic Review , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[33]  A. Algra,et al.  Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: a cohort study , 2005, The Lancet.

[34]  H. Diener,et al.  Clopidogrel for the secondary prevention of stroke , 2005, Expert opinion on pharmacotherapy.

[35]  Antonio Colombo,et al.  Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. , 2005, European heart journal.

[36]  C. Sudlow,et al.  Are Lacunar Strokes Really Different?: A Systematic Review of Differences in Risk Factor Profiles Between Lacunar and Nonlacunar Infarcts , 2005, Stroke.

[37]  R. Sacco,et al.  Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations. , 2005, Archives of neurology.

[38]  H. Diener,et al.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial , 2004, The Lancet.

[39]  A. Térent.  Cerebrovascular Mortality 10 Years After Stroke: A Population-Based Study , 2004, Stroke.

[40]  S. Sacco,et al.  Burden of first-ever ischemic stroke in the oldest old , 2004, Neurology.

[41]  J. Alpert,et al.  Coronary risk evaluation in patients with transient ischemic attack and ischemic stroke: a scientific statement for healthcare professionals from the Stroke Council and the Council on Clinical Cardiology of the American Heart Association/American Stroke Association. , 2003, Stroke.

[42]  Daniel Levy,et al.  The ankle-brachial index in the elderly and risk of stroke, coronary disease, and death: the Framingham Study. , 2003, Archives of internal medicine.

[43]  J. Halperin,et al.  Active-control clinical trials to establish equivalence or noninferiority: methodological and statistical concepts linked to quality. , 2003, American heart journal.

[44]  J. Sejvar,et al.  Risk of Elective Major Noncardiac Surgery After Coronary Stent Insertion , 2012 .

[45]  G. Hankey.  Long-Term Outcome after Ischaemic Stroke/Transient Ischaemic Attack , 2003, Cerebrovascular Diseases.

[46]  R. Baumgartner,et al.  Ischemic Lacunar Stroke in Patients With and Without Potential Mechanism Other Than Small-Artery Disease , 2003, Stroke.

[47]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[48]  Majid Ezzati,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group , 2022 .

[49]  G. Agnelli,et al.  Sulodexide in the treatment of intermittent claudication. Results of a randomized, double-blind, multicentre, placebo-controlled study. , 2002, European heart journal.

[50]  D. O'donoghue,et al.  A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  M. Davidsen,et al.  Long-Term Survival and Causes of Death After Stroke , 2001, Stroke.

[52]  Daniel W. Jones,et al.  Ankle-Brachial Index and 7-Year Ischemic Stroke Incidence: The ARIC Study , 2001, Stroke.

[53]  W. Hiatt,et al.  Medical treatment of peripheral arterial disease and claudication. , 2001, The New England journal of medicine.

[54]  V. Fuster,et al.  Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. , 2000, Circulation.

[55]  C. Warlow,et al.  Prediction of benefit from carotid endar terectomy in individual patients: a risk-modelling study , 1999, The Lancet.

[56]  J. Dormandy,et al.  Intermittent claudication: a condition with underrated risks. , 1999, Seminars in vascular surgery.

[57]  P. Heuschmann,et al.  A prospective community-based study of stroke in Germany--the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. , 1998, Stroke.

[58]  C. Marini,et al.  High stroke incidence in the prospective community-based L'Aquila registry (1994-1998). First year's results. , 1997, Stroke.

[59]  M. A. van 't Hof,et al.  Decreased Ankle/Brachial Indices in Relation to Morbidity and Mortality in Patients with Peripheral Arterial Disease , 1997, Vascular medicine.

[60]  J. Witteman,et al.  Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. , 1997, JAMA.

[61]  David Schultz,et al.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE) , 1996, The Lancet.

[62]  H. Diener,et al.  European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke 1 1 ESPS-2 Writing Committee , 1996, Journal of the Neurological Sciences.

[63]  W Ceusters,et al.  Endarterectomy for moderate symptomatic carotid stenosis: interim results from the MRC European Carotid Surgery Trial , 1996, The Lancet.

[64]  W. Kannel,et al.  The Demographics of Claudication and the Aging of the American Population , 1996, Vascular medicine.

[65]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[66]  S Greenfield,et al.  The Importance of Co-existent Disease in the Occurrence of Postoperative Complications and One-Year Recovery in Patients Undergoing Total Hip Replacement: Comorbidity and Outcomes After Hip Replacement , 1993, Medical care.

[67]  David Lee Gordon,et al.  Classification of Subtype of Acute Ischemic Stroke: Definitions for Use in a Multicenter Clinical Trial , 1993, Stroke.

[68]  L. Kuller,et al.  The ratio of ankle and arm arterial pressure as an independent predictor of mortality. , 1991, Atherosclerosis.

[69]  C. Cimminiello,et al.  Antiplatelet treatment with ticlopidine in unstable angina. A controlled multicenter clinical trial. The Studio della Ticlopidina nell'Angina Instabile Group. , 1990, Circulation.

[70]  D. Bergqvist,et al.  Prevention of myocardial infarction and stroke in patients with intermittent claudication; effects of ticlopidine. Results from STIMS, the Swedish Ticlopidine Multicentre Study , 1990, Journal of internal medicine.

[71]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[72]  A. Andreoli,et al.  Incidence of silent myocardial ischaemia in patients with cerebral ischaemia. , 1988, European heart journal.

[73]  E. Barrett-Connor,et al.  TABLE 1 Prevalence of PAD by traditional assessment : intermittent claudication and pulse palpation % Claudication % Pulse abnormalities Rose Femoral Posterior Dorsalis n Rose , 2005 .

[74]  B. Gersh.  One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis , 2008 .

[75]  Eso Writing,et al.  Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008 , 2008 .

[76]  J. Farmer.  High-dose atorvastatin after stroke or transient ischemic attack. , 2007, Current atherosclerosis reports.

[77]  G. Moneta,et al.  Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study) , 2007 .

[78]  J. Camm,et al.  Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. , 2006, European heart journal.

[79]  D. Sander,et al.  [Significant reduction of vascular risk factors within the framework of the population-based intervention project INVADE--a 2-year follow-up study]. , 2006, Deutsche medizinische Wochenschrift.

[80]  A. Nissinen,et al.  Short and long term association of a single serum cholesterol measurement in middle-aged men in prediction of fatal coronary and other cardiovascular events: A cross-cultural comparison through Europe , 2005, European Journal of Epidemiology.

[81]  J. Mas,et al.  Prévalence des lésions athérothrombotiques asymptomatiques et risque d'événements vasculaires chez un patient ayant eu un accident vasculaire cérébral , 2005 .

[82]  J. Allenberg,et al.  High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. , 2004, Atherosclerosis.

[83]  H. Diener,et al.  Prevention. European Stroke Initiative. , 2004, Cerebrovascular diseases.

[84]  E. Falk,et al.  Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. , 2003, European heart journal.

[85]  M. Criqui,et al.  Peripheral arterial disease detection, awareness, and treatment in primary care. , 2001, JAMA.

[86]  P. Rothwell,et al.  Prediction of benefit from carotid endarterectomy in individual patients: a risk-modelling study. European Carotid Surgery Trialists' Collaborative Group. , 1999, Lancet.

[87]  L. Bouter,et al.  Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: a population-based study. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[88]  J. Witteman,et al.  LOW CONCENTRATIONS, RISK FACTORS FOR STROKE, PERIPHERAL VASCULAR DISEASE, AND CORONARY ARTERY DISEASE , 1998 .

[89]  J. Witteman,et al.  Low Circulating Folate and Vitamin B 6 Concentrations Risk Factors for Stroke, Peripheral Vascular Disease, and Coronary Artery Disease , 1998 .

[90]  R. Hamman,et al.  Diagnostic methods for peripheral arterial disease in the San Luis Valley Diabetes Study. , 1990, Journal of clinical epidemiology.

[91]  A. Lowenthal.  The European Stroke Prevention Study , 1988, Acta neurologica Belgica.